Towards Clinical Radiation Therapy at the Australian Synchrotron: Developments and Future Directions

Start Date
14-03-2018 11:00
End Date
14-03-2018 12:00
Auditorium, Central Building
Speaker's name
Lloyd Smyth
Speaker's institute
University of Melbourne, Australia
Contact name
Eva Jahn
Host name
E. Braeuer-Krisch
Add event to calendar
iCal | vCal

Synchrotron radiotherapy modalities under pre-clinical development at the Australian Synchrotron include microbeam radiation therapy (MRT) and ultra-high dose-rate radiation therapy (Flash-RT). These modalities utilise radiation fields that have physical properties that are distinctly different from conventional radiotherapy (CRT). The radiobiological consequences of these distinct physical properties could be the paradigm shift required to radically improve outcomes for patients where CRT provides minimal benefit. The current challenge is to safely translate these promising findings to a clinical reality. This presentation will discuss some of the key issues that are currently being investigated in the quest to perform a clinical trial of synchrotron radiation therapy at the Australian Synchrotron. These issues include determining dose-equivalence with conventional radiation therapy, systematically characterising normal tissue toxicity and determining optimal treatment sites for MRT.

Visitors from off-site please contact Eva Jahn tel +33 (0)4 76 88 26 19 to arrange for a gate pass.
Requests made by e-mail will be confirmed.
If you do not receive a confirmation e-mail, please contact us by phone.